The landscape of biomedical research and clinical practice is undergoing a structural transition from isolated diagnostic paradigms to unified analytical frameworks. Historically, clinical evaluation relied on compartmentalised observations: radiologists interpreted morphological imaging, pathologists examined histological tissue slices, geneticists analysed targeted DNA sequences and primary care physicians reviewed narrative electronic health records (EHRs). While unimodal

The global financial landscape in the first week of February 2026 was defined by a profound and systemic recalibration of risk, characterised by a transition from liquidity-driven expansion to a regime of rigid valuation discipline. Within this broader market turbulence, the healthcare technology and digital health sectors experienced heightened volatility, acting as a microcosm of the tension between long-term innovation and short-term capital constraints. While the sell-off